↓ Skip to main content

Dove Medical Press

Spotlight on Furmonertinib (Alflutinib, AST2818). The Swiss Army Knife (del19, L858R, T790M, Exon 20 Insertions, “uncommon-G719X, S768I, L861Q”) Among the Third-Generation EGFR TKIs?

Overview of attention for article published in Lung Cancer: Targets and Therapy, October 2022
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#28 of 128)
  • Good Attention Score compared to outputs of the same age (72nd percentile)

Mentioned by

twitter
3 X users
patent
1 patent

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
8 Mendeley
Title
Spotlight on Furmonertinib (Alflutinib, AST2818). The Swiss Army Knife (del19, L858R, T790M, Exon 20 Insertions, “uncommon-G719X, S768I, L861Q”) Among the Third-Generation EGFR TKIs?
Published in
Lung Cancer: Targets and Therapy, October 2022
DOI 10.2147/lctt.s385437
Pubmed ID
Authors

Shannon S Zhang, Sai-hong Ignatius Ou

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 13%
Student > Bachelor 1 13%
Student > Postgraduate 1 13%
Student > Master 1 13%
Unknown 4 50%
Readers by discipline Count As %
Unspecified 1 13%
Biochemistry, Genetics and Molecular Biology 1 13%
Business, Management and Accounting 1 13%
Social Sciences 1 13%
Unknown 4 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 August 2023.
All research outputs
#6,761,242
of 25,392,582 outputs
Outputs from Lung Cancer: Targets and Therapy
#28
of 128 outputs
Outputs of similar age
#121,849
of 439,301 outputs
Outputs of similar age from Lung Cancer: Targets and Therapy
#1
of 3 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 128 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 439,301 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them